FDAnews Drug Daily Bulletin

THERAPEUTIC PROSPECTS BEYOND VIOXX: PENN STUDY SUGGESTS NEW CLASS OF ANTI-INFLAMMATORY DRUGS

April 18, 2006
A A

Researchers at the University of Pennsylvania School of Medicine have clarified the mechanism by which drugs like Celebrex and Vioxx cause heart problems, in multiple animal models. The findings offer the prospect of a new generation of anti-inflammatory drugs that bypass this issue, as reported in the April 13 advanced online edition and May print issue of The Journal of Clinical Investigation.
AScribe